Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Horizon Pharma PLC (NASDAQ:HZNP)

13.65
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
9.45
Today|||52-Week Range
21.98
-15.64%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues310.3M220.9M289.5M271.6M
 
 
 
 
 
Cost of Goods Sold82.4M67.6M58.6M55.4M
 
 
 
 
 
Depreciation And Amortization67.4M71.5M71.6M70.1M
 
 
 
 
 
 
Operating ExpensesGross Income160.6M81.7M159.4M146.1M
 
 
 
 
 
General Expenses224.7M177.5M341.0M168.7M
 
 
 
 
 
Research And Development24.0M13.1M162.8M17.8M
 
 
 
 
 
Total Operating Expenses374.5M316.6M471.2M294.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-64.1M-95.8M-181.7M-22.6M
 
 
 
 
 
Extraordinary Charge-66.0M-10.1M-4.0M-3.2M
 
 
 
 
 
Interest Expense On Debt28.9M32.0M31.6M31.7M
 
 
 
 
 
Other Expenses-881.0K-224.0K6.0M667.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-159.8M-138.1M-211.3M-56.8M
 
 
 
 
 
Income Taxes-29.3M-47.6M-1.8M-7.2M
 
 
 
 
 
Net Income-130.5M-90.6M-209.5M-64.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS161.4M162.0M162.9M163.4M
 
 
 
 
 
Shares To Calculate EPS Diluted161.4M162.0M162.9M163.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81-$0.56-$1.29-$0.39
 
 
 
 
 
EPS Diluted-$0.81-$0.56-$1.29-$0.39